Medical Regulation > Nova Content
Recent news reports attacking the US drug approval process are not considering all the facts. The Food and Drug Administration (FDA) has been under fire for several... Read More »
Biological pharmaceuticals are therapeutic drugs made from human or animal materials rather than chemicals, often indicated for immune system-related deficiencies... Read More »
Science Applications International Corporation (SAIC) announced today it was awarded a prime contract by the US Naval Medical Logistics Command (NMLC) to provide... Read More »
The US Food and Drug Administration (FDA) today issued three draft guidance documents on biosimilar product development to assist industry in developing these... Read More »
Two new blood thinners, Xarelto (rivaroxaban) and Pradaxa (dabigatran etexilate) have been approved by the FDA for patients with atrial fibrillation that is not... Read More »
Transparency Life Sciences, LLC (TLS), a new drug development company, has launched a thoroughly innovative platform for clinical studies, with an objective of... Read More »
Since the early 1990s, a popular procedure for relieving the pain of spinal column fractures in patients with osteoporosis was vertebroplasty – the injection of ... Read More »
Comments
maria luz caliboPatient-centered outcomes has its advantages and disadvantages. The good thing about it is that patients are given the autonomy to make informed decisions about his/her treatment.
Feb 3, 2012
Aurora SterlingAlways nice to hear about patient-focused advances in medicine.
Feb 2, 2012
A new study by food safety researchers at Drexel University demonstrates that plasma can be an effective method for killing pathogens on uncooked poultry. The most... Read More »
Pfizer announced that the U.S. Food and Drug Administration has approved their kidney cancer drug INLYTA (axinib). The treatment will be available for patients... Read More »
The horrors of Alzheimer’s disease are well known, and the specter of this disease will fall over most of us in one way or another. Enormous quantities of ... Read More »
Merck announced today the establishment of a new Research and Development headquarters in Beijing, China, which is part of a $1.5 billion dollar investment push for... Read More »
Amgen announced today that the FDA has agreed to modify the requirements of the Nplate® Risk Evaluation and Mitigation Strategy Program (REMS). When reviewing the ... Read More »
McKesson High Volume Solutions will introduce ExpressRx Track this week in New Orleans at the 46th American Society of Health-system Pharmacists Midyear Clinical... Read More »
Boston Scientific announced its next-generation drug-eluting stent was approved by the Federal Food and Drug Administration. With it’s innovative platinum... Read More »
CHICAGO (Reuters) - An experimental drug that chokes off the blood supply to fat cells helped obese monkeys slim down, a sign that it may work in people... Read More »
Two major pharmaceutical companies, Amylin Pharmaceuticals Inc (“Amylin”) and Eli Lilly and Company (“Lilly”), announced today their plans to... Read More »
(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »
On October 31st, the company Medtronic received US Federal Food and Drug Administration approval to treat Narrow Iliac arteries with the use of the Cobalt Chromium... Read More »
Medtronic Inc has developed a new device for the treatment of peripheral artery disease. This new FDA approved device, dubbed the Assurant Cobalt... Read More »
On August 25, 2011 Johnson & Johnson Pharmaceutical Research and Development, L.L.C (J&JPRD) received approval from the US Food and Drug... Read More »